nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Calcitriol—osteoporosis	0.0919	0.181	CbGbCtD
Maraviroc—CYP3A4—Estropipate—osteoporosis	0.0919	0.181	CbGbCtD
Maraviroc—CYP3A4—Ergocalciferol—osteoporosis	0.0735	0.145	CbGbCtD
Maraviroc—CYP3A4—Raloxifene—osteoporosis	0.0613	0.121	CbGbCtD
Maraviroc—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0592	0.117	CbGbCtD
Maraviroc—CYP3A4—Cholecalciferol—osteoporosis	0.0473	0.0934	CbGbCtD
Maraviroc—CYP3A4—Conjugated Estrogens—osteoporosis	0.0435	0.0858	CbGbCtD
Maraviroc—CYP3A4—Estradiol—osteoporosis	0.0382	0.0753	CbGbCtD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00378	0.0518	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—NFATC1—osteoporosis	0.00369	0.0506	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CALCR—osteoporosis	0.00206	0.0282	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PTH1R—osteoporosis	0.00206	0.0282	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—CNR2—osteoporosis	0.00174	0.0238	CbGpPWpGaD
Maraviroc—CCR5—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	0.00161	0.0221	CbGpPWpGaD
Maraviroc—CCR5—IL12-mediated signaling events—IL1B—osteoporosis	0.00151	0.0207	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—PSMA5—osteoporosis	0.0015	0.0205	CbGpPWpGaD
Maraviroc—CCR5—HIV Infection—PSMA2—osteoporosis	0.0015	0.0205	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	0.00138	0.019	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PTH1R—osteoporosis	0.00116	0.0159	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CALCR—osteoporosis	0.00116	0.0159	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL1B—osteoporosis	0.00109	0.0149	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PTH—osteoporosis	0.00108	0.0148	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PTH1R—osteoporosis	0.00106	0.0145	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CALCR—osteoporosis	0.00106	0.0145	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CNR2—osteoporosis	0.00105	0.0144	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—WNT1—osteoporosis	0.00099	0.0136	CbGpPWpGaD
Maraviroc—CCR5—Disease—PKM—osteoporosis	0.000985	0.0135	CbGpPWpGaD
Maraviroc—CCR5—Disease—SOST—osteoporosis	0.000985	0.0135	CbGpPWpGaD
Maraviroc—CCR5—Disease—PGLS—osteoporosis	0.000934	0.0128	CbGpPWpGaD
Maraviroc—CCR5—Disease—ANTXR2—osteoporosis	0.000934	0.0128	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—ADCY5—osteoporosis	0.000926	0.0127	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—MGLL—osteoporosis	0.000924	0.0127	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—PTHLH—osteoporosis	0.000896	0.0123	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—TGFB1—osteoporosis	0.000847	0.0116	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—MGLL—osteoporosis	0.000839	0.0115	CbGpPWpGaD
Maraviroc—CCR5—Peptide ligand-binding receptors—POMC—osteoporosis	0.000808	0.0111	CbGpPWpGaD
Maraviroc—CCR5—Disease—GSN—osteoporosis	0.000794	0.0109	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CALCA—osteoporosis	0.000789	0.0108	CbGpPWpGaD
Maraviroc—CCR5—Disease—LRP5—osteoporosis	0.000691	0.00947	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SOST—osteoporosis	0.00069	0.00946	CbGpPWpGaD
Maraviroc—CCR5—G alpha (i) signalling events—POMC—osteoporosis	0.000681	0.00934	CbGpPWpGaD
Maraviroc—CCR5—Disease—LRP6—osteoporosis	0.000661	0.00906	CbGpPWpGaD
Maraviroc—CCR5—TCR Signaling Pathway—IL6—osteoporosis	0.000638	0.00875	CbGpPWpGaD
Maraviroc—CCR5—Disease—LTF—osteoporosis	0.000635	0.0087	CbGpPWpGaD
Maraviroc—CCR5—Disease—RPL24—osteoporosis	0.000635	0.0087	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTH1R—osteoporosis	0.000624	0.00855	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CALCR—osteoporosis	0.000624	0.00855	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PTH—osteoporosis	0.000611	0.00837	CbGpPWpGaD
Maraviroc—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000604	0.00828	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CNR2—osteoporosis	0.000595	0.00816	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PTH—osteoporosis	0.000555	0.0076	CbGpPWpGaD
Maraviroc—CCR5—Disease—ACP5—osteoporosis	0.00055	0.00754	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000542	0.00743	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CNR2—osteoporosis	0.000541	0.00741	CbGpPWpGaD
Maraviroc—CCR5—Disease—TPI1—osteoporosis	0.000512	0.00701	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—WNT1—osteoporosis	0.000508	0.00697	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PTHLH—osteoporosis	0.000506	0.00694	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MGLL—osteoporosis	0.000496	0.00679	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LRP5—osteoporosis	0.000484	0.00663	CbGpPWpGaD
Maraviroc—CCR5—Disease—P4HB—osteoporosis	0.000481	0.00659	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.00048	0.00657	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000473	0.00649	CbGpPWpGaD
Maraviroc—CCR5—Disease—GAPDH—osteoporosis	0.000472	0.00647	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LRP6—osteoporosis	0.000463	0.00634	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PTHLH—osteoporosis	0.00046	0.0063	CbGpPWpGaD
Maraviroc—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000452	0.00619	CbGpPWpGaD
Maraviroc—CCR5—Disease—NFATC1—osteoporosis	0.000449	0.00615	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CALCA—osteoporosis	0.000446	0.00611	CbGpPWpGaD
Maraviroc—CCR5—Disease—DKK1—osteoporosis	0.000445	0.0061	CbGpPWpGaD
Maraviroc—CCR5—Disease—WNT1—osteoporosis	0.000429	0.00588	CbGpPWpGaD
Maraviroc—CCR5—Disease—FGA—osteoporosis	0.000417	0.00572	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—POMC—osteoporosis	0.000413	0.00566	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CALCA—osteoporosis	0.000405	0.00555	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TLN1—osteoporosis	0.000391	0.00535	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000389	0.00533	CbGpPWpGaD
Maraviroc—CCR5—Disease—ENO1—osteoporosis	0.000372	0.0051	CbGpPWpGaD
Maraviroc—CCR5—Disease—PSMA2—osteoporosis	0.000366	0.00502	CbGpPWpGaD
Maraviroc—CCR5—Disease—PSMA5—osteoporosis	0.000366	0.00502	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000347	0.00475	CbGpPWpGaD
Maraviroc—CCR5—Disease—CALCA—osteoporosis	0.000341	0.00468	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—P4HB—osteoporosis	0.000337	0.00462	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTH—osteoporosis	0.000328	0.00449	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Ibandronate—osteoporosis	0.000324	0.00077	CcSEcCtD
Maraviroc—Myalgia—Pamidronate—osteoporosis	0.000323	0.000769	CcSEcCtD
Maraviroc—Anxiety—Pamidronate—osteoporosis	0.000322	0.000767	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—RAP1A—osteoporosis	0.000322	0.00441	CbGpPWpGaD
Maraviroc—Body temperature increased—Alendronate—osteoporosis	0.000321	0.000764	CcSEcCtD
Maraviroc—Abdominal pain—Alendronate—osteoporosis	0.000321	0.000764	CcSEcCtD
Maraviroc—Sinusitis—Estradiol—osteoporosis	0.000321	0.000764	CcSEcCtD
Maraviroc—Shock—Risedronate—osteoporosis	0.000321	0.000763	CcSEcCtD
Maraviroc—Anaemia—Zoledronate—osteoporosis	0.000321	0.000763	CcSEcCtD
Maraviroc—Nervous system disorder—Risedronate—osteoporosis	0.00032	0.000761	CcSEcCtD
Maraviroc—Discomfort—Pamidronate—osteoporosis	0.00032	0.00076	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CNR2—osteoporosis	0.000319	0.00438	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADCY5—osteoporosis	0.000317	0.00435	CbGpPWpGaD
Maraviroc—Skin disorder—Risedronate—osteoporosis	0.000317	0.000754	CcSEcCtD
Maraviroc—Gastrointestinal pain—Calcitriol—osteoporosis	0.000317	0.000754	CcSEcCtD
Maraviroc—Abdominal pain—Raloxifene—osteoporosis	0.000316	0.000752	CcSEcCtD
Maraviroc—Body temperature increased—Raloxifene—osteoporosis	0.000316	0.000752	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NFATC1—osteoporosis	0.000314	0.00431	CbGpPWpGaD
Maraviroc—Abdominal pain—Ibandronate—osteoporosis	0.000313	0.000744	CcSEcCtD
Maraviroc—Body temperature increased—Ibandronate—osteoporosis	0.000313	0.000744	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—DKK1—osteoporosis	0.000312	0.00427	CbGpPWpGaD
Maraviroc—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000312	0.00427	CbGpPWpGaD
Maraviroc—Syncope—Zoledronate—osteoporosis	0.000311	0.00074	CcSEcCtD
Maraviroc—Leukopenia—Zoledronate—osteoporosis	0.000311	0.000739	CcSEcCtD
Maraviroc—Oedema—Pamidronate—osteoporosis	0.00031	0.000738	CcSEcCtD
Maraviroc—CCR5—Disease—KL—osteoporosis	0.00031	0.00425	CbGpPWpGaD
Maraviroc—Infection—Pamidronate—osteoporosis	0.000308	0.000733	CcSEcCtD
Maraviroc—Rhinitis—Estradiol—osteoporosis	0.000308	0.000733	CcSEcCtD
Maraviroc—Abdominal pain—Calcitriol—osteoporosis	0.000306	0.000729	CcSEcCtD
Maraviroc—Body temperature increased—Calcitriol—osteoporosis	0.000306	0.000729	CcSEcCtD
Maraviroc—Shock—Pamidronate—osteoporosis	0.000305	0.000726	CcSEcCtD
Maraviroc—Loss of consciousness—Zoledronate—osteoporosis	0.000305	0.000726	CcSEcCtD
Maraviroc—Pharyngitis—Estradiol—osteoporosis	0.000305	0.000725	CcSEcCtD
Maraviroc—Hypersensitivity—Estropipate—osteoporosis	0.000304	0.000723	CcSEcCtD
Maraviroc—Nervous system disorder—Pamidronate—osteoporosis	0.000304	0.000723	CcSEcCtD
Maraviroc—Urinary tract disorder—Estradiol—osteoporosis	0.000303	0.000722	CcSEcCtD
Maraviroc—Vomiting—Etidronic acid—osteoporosis	0.000303	0.000722	CcSEcCtD
Maraviroc—Cough—Zoledronate—osteoporosis	0.000303	0.00072	CcSEcCtD
Maraviroc—Connective tissue disorder—Estradiol—osteoporosis	0.000302	0.000718	CcSEcCtD
Maraviroc—Urethral disorder—Estradiol—osteoporosis	0.000301	0.000716	CcSEcCtD
Maraviroc—Rash—Etidronic acid—osteoporosis	0.000301	0.000716	CcSEcCtD
Maraviroc—Convulsion—Zoledronate—osteoporosis	0.000301	0.000715	CcSEcCtD
Maraviroc—Dermatitis—Etidronic acid—osteoporosis	0.000301	0.000715	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—WNT1—osteoporosis	0.0003	0.00412	CbGpPWpGaD
Maraviroc—Syncope—Conjugated Estrogens—osteoporosis	0.0003	0.000713	CcSEcCtD
Maraviroc—Hypersensitivity—Alendronate—osteoporosis	0.000299	0.000712	CcSEcCtD
Maraviroc—Headache—Etidronic acid—osteoporosis	0.000299	0.000711	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000297	0.000707	CcSEcCtD
Maraviroc—Asthenia—Estropipate—osteoporosis	0.000296	0.000704	CcSEcCtD
Maraviroc—Anorexia—Pamidronate—osteoporosis	0.000296	0.000703	CcSEcCtD
Maraviroc—Myalgia—Zoledronate—osteoporosis	0.000295	0.000703	CcSEcCtD
Maraviroc—Insomnia—Risedronate—osteoporosis	0.000295	0.000702	CcSEcCtD
Maraviroc—Anxiety—Zoledronate—osteoporosis	0.000294	0.0007	CcSEcCtD
Maraviroc—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000294	0.000699	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000293	0.000698	CcSEcCtD
Maraviroc—Paraesthesia—Risedronate—osteoporosis	0.000293	0.000697	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGA—osteoporosis	0.000292	0.004	CbGpPWpGaD
Maraviroc—Pruritus—Estropipate—osteoporosis	0.000292	0.000695	CcSEcCtD
Maraviroc—Discomfort—Zoledronate—osteoporosis	0.000292	0.000694	CcSEcCtD
Maraviroc—Asthenia—Alendronate—osteoporosis	0.000292	0.000694	CcSEcCtD
Maraviroc—Hypersensitivity—Ibandronate—osteoporosis	0.000292	0.000694	CcSEcCtD
Maraviroc—Cough—Conjugated Estrogens—osteoporosis	0.000292	0.000694	CcSEcCtD
Maraviroc—Erythema multiforme—Estradiol—osteoporosis	0.00029	0.000691	CcSEcCtD
Maraviroc—Convulsion—Conjugated Estrogens—osteoporosis	0.00029	0.000689	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000289	0.000687	CcSEcCtD
Maraviroc—Fatigue—Ethinyl Estradiol—osteoporosis	0.000288	0.000686	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—ADCY5—osteoporosis	0.000288	0.00395	CbGpPWpGaD
Maraviroc—Pruritus—Alendronate—osteoporosis	0.000288	0.000684	CcSEcCtD
Maraviroc—Eye disorder—Estradiol—osteoporosis	0.000287	0.000683	CcSEcCtD
Maraviroc—Constipation—Ethinyl Estradiol—osteoporosis	0.000286	0.000681	CcSEcCtD
Maraviroc—Hypersensitivity—Calcitriol—osteoporosis	0.000285	0.000679	CcSEcCtD
Maraviroc—Cardiac disorder—Estradiol—osteoporosis	0.000285	0.000678	CcSEcCtD
Maraviroc—Myalgia—Conjugated Estrogens—osteoporosis	0.000284	0.000677	CcSEcCtD
Maraviroc—Asthenia—Ibandronate—osteoporosis	0.000284	0.000675	CcSEcCtD
Maraviroc—Anxiety—Conjugated Estrogens—osteoporosis	0.000283	0.000674	CcSEcCtD
Maraviroc—Nausea—Etidronic acid—osteoporosis	0.000283	0.000674	CcSEcCtD
Maraviroc—Oedema—Zoledronate—osteoporosis	0.000283	0.000674	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000283	0.000672	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000282	0.000672	CcSEcCtD
Maraviroc—Diarrhoea—Estropipate—osteoporosis	0.000282	0.000672	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Risedronate—osteoporosis	0.000282	0.00067	CcSEcCtD
Maraviroc—Infection—Zoledronate—osteoporosis	0.000281	0.000669	CcSEcCtD
Maraviroc—Fatigue—Risedronate—osteoporosis	0.000281	0.000669	CcSEcCtD
Maraviroc—Insomnia—Pamidronate—osteoporosis	0.00028	0.000667	CcSEcCtD
Maraviroc—Pruritus—Ibandronate—osteoporosis	0.00028	0.000666	CcSEcCtD
Maraviroc—Pain—Risedronate—osteoporosis	0.000279	0.000664	CcSEcCtD
Maraviroc—Constipation—Risedronate—osteoporosis	0.000279	0.000664	CcSEcCtD
Maraviroc—Angiopathy—Estradiol—osteoporosis	0.000279	0.000663	CcSEcCtD
Maraviroc—Shock—Zoledronate—osteoporosis	0.000279	0.000663	CcSEcCtD
Maraviroc—Paraesthesia—Pamidronate—osteoporosis	0.000278	0.000662	CcSEcCtD
Maraviroc—Diarrhoea—Alendronate—osteoporosis	0.000278	0.000662	CcSEcCtD
Maraviroc—Asthenia—Calcitriol—osteoporosis	0.000278	0.000661	CcSEcCtD
Maraviroc—Nervous system disorder—Zoledronate—osteoporosis	0.000278	0.000661	CcSEcCtD
Maraviroc—Mediastinal disorder—Estradiol—osteoporosis	0.000277	0.000659	CcSEcCtD
Maraviroc—Skin disorder—Zoledronate—osteoporosis	0.000275	0.000654	CcSEcCtD
Maraviroc—Pruritus—Calcitriol—osteoporosis	0.000274	0.000652	CcSEcCtD
Maraviroc—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000274	0.000651	CcSEcCtD
Maraviroc—Diarrhoea—Raloxifene—osteoporosis	0.000274	0.000651	CcSEcCtD
Maraviroc—Dizziness—Estropipate—osteoporosis	0.000273	0.000649	CcSEcCtD
Maraviroc—Oedema—Conjugated Estrogens—osteoporosis	0.000273	0.000649	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PTHLH—osteoporosis	0.000272	0.00372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BMP2—osteoporosis	0.000272	0.00372	CbGpPWpGaD
Maraviroc—Alopecia—Estradiol—osteoporosis	0.000271	0.000646	CcSEcCtD
Maraviroc—Infection—Conjugated Estrogens—osteoporosis	0.000271	0.000644	CcSEcCtD
Maraviroc—Diarrhoea—Ibandronate—osteoporosis	0.000271	0.000644	CcSEcCtD
Maraviroc—Anorexia—Zoledronate—osteoporosis	0.00027	0.000642	CcSEcCtD
Maraviroc—Decreased appetite—Pamidronate—osteoporosis	0.00027	0.000641	CcSEcCtD
Maraviroc—Mental disorder—Estradiol—osteoporosis	0.000269	0.00064	CcSEcCtD
Maraviroc—Dizziness—Alendronate—osteoporosis	0.000269	0.000639	CcSEcCtD
Maraviroc—Shock—Conjugated Estrogens—osteoporosis	0.000268	0.000638	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000268	0.000637	CcSEcCtD
Maraviroc—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000267	0.000636	CcSEcCtD
Maraviroc—Erythema—Estradiol—osteoporosis	0.000267	0.000636	CcSEcCtD
Maraviroc—Malnutrition—Estradiol—osteoporosis	0.000267	0.000636	CcSEcCtD
Maraviroc—Fatigue—Pamidronate—osteoporosis	0.000267	0.000636	CcSEcCtD
Maraviroc—Gastrointestinal pain—Risedronate—osteoporosis	0.000267	0.000634	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGB—osteoporosis	0.000266	0.00364	CbGpPWpGaD
Maraviroc—Pain—Pamidronate—osteoporosis	0.000265	0.000631	CcSEcCtD
Maraviroc—Constipation—Pamidronate—osteoporosis	0.000265	0.000631	CcSEcCtD
Maraviroc—Diarrhoea—Calcitriol—osteoporosis	0.000265	0.000631	CcSEcCtD
Maraviroc—Skin disorder—Conjugated Estrogens—osteoporosis	0.000265	0.00063	CcSEcCtD
Maraviroc—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000264	0.000629	CcSEcCtD
Maraviroc—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000264	0.000629	CcSEcCtD
Maraviroc—Dizziness—Raloxifene—osteoporosis	0.000264	0.000629	CcSEcCtD
Maraviroc—Flatulence—Estradiol—osteoporosis	0.000264	0.000627	CcSEcCtD
Maraviroc—Vomiting—Estropipate—osteoporosis	0.000262	0.000624	CcSEcCtD
Maraviroc—Dizziness—Ibandronate—osteoporosis	0.000262	0.000623	CcSEcCtD
Maraviroc—Rash—Estropipate—osteoporosis	0.00026	0.000619	CcSEcCtD
Maraviroc—Dermatitis—Estropipate—osteoporosis	0.00026	0.000618	CcSEcCtD
Maraviroc—Anorexia—Conjugated Estrogens—osteoporosis	0.00026	0.000618	CcSEcCtD
Maraviroc—Headache—Estropipate—osteoporosis	0.000259	0.000615	CcSEcCtD
Maraviroc—Vomiting—Alendronate—osteoporosis	0.000258	0.000615	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000258	0.000614	CcSEcCtD
Maraviroc—Body temperature increased—Risedronate—osteoporosis	0.000258	0.000613	CcSEcCtD
Maraviroc—Abdominal pain—Risedronate—osteoporosis	0.000258	0.000613	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PSMA2—osteoporosis	0.000257	0.00352	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PSMA5—osteoporosis	0.000257	0.00352	CbGpPWpGaD
Maraviroc—Rash—Alendronate—osteoporosis	0.000256	0.00061	CcSEcCtD
Maraviroc—Insomnia—Zoledronate—osteoporosis	0.000256	0.000609	CcSEcCtD
Maraviroc—Dermatitis—Alendronate—osteoporosis	0.000256	0.000609	CcSEcCtD
Maraviroc—Headache—Alendronate—osteoporosis	0.000255	0.000606	CcSEcCtD
Maraviroc—Paraesthesia—Zoledronate—osteoporosis	0.000254	0.000605	CcSEcCtD
Maraviroc—Vomiting—Raloxifene—osteoporosis	0.000254	0.000605	CcSEcCtD
Maraviroc—Gastrointestinal pain—Pamidronate—osteoporosis	0.000254	0.000603	CcSEcCtD
Maraviroc—Rash—Raloxifene—osteoporosis	0.000252	0.0006	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000252	0.00345	CbGpPWpGaD
Maraviroc—Dermatitis—Raloxifene—osteoporosis	0.000252	0.000599	CcSEcCtD
Maraviroc—Vomiting—Ibandronate—osteoporosis	0.000252	0.000599	CcSEcCtD
Maraviroc—Tremor—Estradiol—osteoporosis	0.000251	0.000596	CcSEcCtD
Maraviroc—Headache—Raloxifene—osteoporosis	0.00025	0.000596	CcSEcCtD
Maraviroc—Rash—Ibandronate—osteoporosis	0.00025	0.000594	CcSEcCtD
Maraviroc—Dermatitis—Ibandronate—osteoporosis	0.000249	0.000593	CcSEcCtD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000249	0.00341	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000248	0.000591	CcSEcCtD
Maraviroc—Headache—Ibandronate—osteoporosis	0.000248	0.00059	CcSEcCtD
Maraviroc—Insomnia—Conjugated Estrogens—osteoporosis	0.000247	0.000587	CcSEcCtD
Maraviroc—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000246	0.000586	CcSEcCtD
Maraviroc—Vomiting—Calcitriol—osteoporosis	0.000246	0.000586	CcSEcCtD
Maraviroc—Decreased appetite—Zoledronate—osteoporosis	0.000246	0.000586	CcSEcCtD
Maraviroc—Nausea—Estropipate—osteoporosis	0.000245	0.000583	CcSEcCtD
Maraviroc—Abdominal pain—Pamidronate—osteoporosis	0.000245	0.000583	CcSEcCtD
Maraviroc—Body temperature increased—Pamidronate—osteoporosis	0.000245	0.000583	CcSEcCtD
Maraviroc—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000245	0.000583	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000245	0.000582	CcSEcCtD
Maraviroc—Rash—Calcitriol—osteoporosis	0.000244	0.000581	CcSEcCtD
Maraviroc—Fatigue—Zoledronate—osteoporosis	0.000244	0.000581	CcSEcCtD
Maraviroc—Dermatitis—Calcitriol—osteoporosis	0.000244	0.000581	CcSEcCtD
Maraviroc—CCR5—Disease—ADCY5—osteoporosis	0.000243	0.00333	CbGpPWpGaD
Maraviroc—Headache—Calcitriol—osteoporosis	0.000243	0.000577	CcSEcCtD
Maraviroc—Pain—Zoledronate—osteoporosis	0.000242	0.000576	CcSEcCtD
Maraviroc—Constipation—Zoledronate—osteoporosis	0.000242	0.000576	CcSEcCtD
Maraviroc—Nausea—Alendronate—osteoporosis	0.000241	0.000574	CcSEcCtD
Maraviroc—Hypersensitivity—Risedronate—osteoporosis	0.00024	0.000572	CcSEcCtD
Maraviroc—Asthenia—Ethinyl Estradiol—osteoporosis	0.00024	0.000571	CcSEcCtD
Maraviroc—Syncope—Estradiol—osteoporosis	0.00024	0.000571	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CALCA—osteoporosis	0.000239	0.00328	CbGpPWpGaD
Maraviroc—Nausea—Raloxifene—osteoporosis	0.000237	0.000565	CcSEcCtD
Maraviroc—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000237	0.000564	CcSEcCtD
Maraviroc—Pruritus—Ethinyl Estradiol—osteoporosis	0.000237	0.000563	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000235	0.00056	CcSEcCtD
Maraviroc—Fatigue—Conjugated Estrogens—osteoporosis	0.000235	0.000559	CcSEcCtD
Maraviroc—Nausea—Ibandronate—osteoporosis	0.000235	0.000559	CcSEcCtD
Maraviroc—Loss of consciousness—Estradiol—osteoporosis	0.000235	0.000559	CcSEcCtD
Maraviroc—Asthenia—Risedronate—osteoporosis	0.000234	0.000557	CcSEcCtD
Maraviroc—Cough—Estradiol—osteoporosis	0.000233	0.000555	CcSEcCtD
Maraviroc—Pain—Conjugated Estrogens—osteoporosis	0.000233	0.000555	CcSEcCtD
Maraviroc—Constipation—Conjugated Estrogens—osteoporosis	0.000233	0.000555	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—POMC—osteoporosis	0.000233	0.0032	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Zoledronate—osteoporosis	0.000232	0.000551	CcSEcCtD
Maraviroc—Pruritus—Risedronate—osteoporosis	0.000231	0.000549	CcSEcCtD
Maraviroc—Nausea—Calcitriol—osteoporosis	0.00023	0.000547	CcSEcCtD
Maraviroc—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000229	0.000544	CcSEcCtD
Maraviroc—Hypersensitivity—Pamidronate—osteoporosis	0.000228	0.000543	CcSEcCtD
Maraviroc—Myalgia—Estradiol—osteoporosis	0.000228	0.000542	CcSEcCtD
Maraviroc—Anxiety—Estradiol—osteoporosis	0.000227	0.00054	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000226	0.000538	CcSEcCtD
Maraviroc—Discomfort—Estradiol—osteoporosis	0.000225	0.000535	CcSEcCtD
Maraviroc—Abdominal pain—Zoledronate—osteoporosis	0.000224	0.000533	CcSEcCtD
Maraviroc—Body temperature increased—Zoledronate—osteoporosis	0.000224	0.000533	CcSEcCtD
Maraviroc—CCR5—Disease—MTHFR—osteoporosis	0.000223	0.00306	CbGpPWpGaD
Maraviroc—Diarrhoea—Risedronate—osteoporosis	0.000223	0.000531	CcSEcCtD
Maraviroc—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000223	0.00053	CcSEcCtD
Maraviroc—Asthenia—Pamidronate—osteoporosis	0.000222	0.000529	CcSEcCtD
Maraviroc—Dizziness—Ethinyl Estradiol—osteoporosis	0.000221	0.000526	CcSEcCtD
Maraviroc—Pruritus—Pamidronate—osteoporosis	0.000219	0.000522	CcSEcCtD
Maraviroc—Oedema—Estradiol—osteoporosis	0.000218	0.000519	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KL—osteoporosis	0.000217	0.00298	CbGpPWpGaD
Maraviroc—Infection—Estradiol—osteoporosis	0.000217	0.000516	CcSEcCtD
Maraviroc—Dizziness—Risedronate—osteoporosis	0.000216	0.000513	CcSEcCtD
Maraviroc—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000216	0.000513	CcSEcCtD
Maraviroc—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000216	0.000513	CcSEcCtD
Maraviroc—Shock—Estradiol—osteoporosis	0.000215	0.000511	CcSEcCtD
Maraviroc—Nervous system disorder—Estradiol—osteoporosis	0.000214	0.000509	CcSEcCtD
Maraviroc—Vomiting—Ethinyl Estradiol—osteoporosis	0.000213	0.000506	CcSEcCtD
Maraviroc—CCR5—Disease—IRS2—osteoporosis	0.000212	0.00291	CbGpPWpGaD
Maraviroc—Diarrhoea—Pamidronate—osteoporosis	0.000212	0.000505	CcSEcCtD
Maraviroc—Skin disorder—Estradiol—osteoporosis	0.000212	0.000504	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—POMC—osteoporosis	0.000212	0.0029	CbGpPWpGaD
Maraviroc—Rash—Ethinyl Estradiol—osteoporosis	0.000211	0.000502	CcSEcCtD
Maraviroc—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000211	0.000501	CcSEcCtD
Maraviroc—Headache—Ethinyl Estradiol—osteoporosis	0.00021	0.000499	CcSEcCtD
Maraviroc—Hypersensitivity—Zoledronate—osteoporosis	0.000209	0.000496	CcSEcCtD
Maraviroc—Vomiting—Risedronate—osteoporosis	0.000207	0.000493	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6R—osteoporosis	0.000207	0.00283	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000207	0.00283	CbGpPWpGaD
Maraviroc—Rash—Risedronate—osteoporosis	0.000206	0.000489	CcSEcCtD
Maraviroc—Dermatitis—Risedronate—osteoporosis	0.000205	0.000489	CcSEcCtD
Maraviroc—Dizziness—Pamidronate—osteoporosis	0.000205	0.000488	CcSEcCtD
Maraviroc—Headache—Risedronate—osteoporosis	0.000204	0.000486	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000204	0.0028	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000204	0.00279	CbGpPWpGaD
Maraviroc—Asthenia—Zoledronate—osteoporosis	0.000203	0.000483	CcSEcCtD
Maraviroc—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000201	0.000478	CcSEcCtD
Maraviroc—Pruritus—Zoledronate—osteoporosis	0.0002	0.000477	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000199	0.000473	CcSEcCtD
Maraviroc—Nausea—Ethinyl Estradiol—osteoporosis	0.000199	0.000473	CcSEcCtD
Maraviroc—Insomnia—Estradiol—osteoporosis	0.000197	0.00047	CcSEcCtD
Maraviroc—Vomiting—Pamidronate—osteoporosis	0.000197	0.000469	CcSEcCtD
Maraviroc—Paraesthesia—Estradiol—osteoporosis	0.000196	0.000466	CcSEcCtD
Maraviroc—Asthenia—Conjugated Estrogens—osteoporosis	0.000196	0.000465	CcSEcCtD
Maraviroc—Rash—Pamidronate—osteoporosis	0.000195	0.000465	CcSEcCtD
Maraviroc—Dermatitis—Pamidronate—osteoporosis	0.000195	0.000465	CcSEcCtD
Maraviroc—Headache—Pamidronate—osteoporosis	0.000194	0.000462	CcSEcCtD
Maraviroc—Diarrhoea—Zoledronate—osteoporosis	0.000194	0.000461	CcSEcCtD
Maraviroc—Nausea—Risedronate—osteoporosis	0.000194	0.000461	CcSEcCtD
Maraviroc—Pruritus—Conjugated Estrogens—osteoporosis	0.000193	0.000459	CcSEcCtD
Maraviroc—Decreased appetite—Estradiol—osteoporosis	0.00019	0.000451	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Estradiol—osteoporosis	0.000188	0.000448	CcSEcCtD
Maraviroc—Fatigue—Estradiol—osteoporosis	0.000188	0.000448	CcSEcCtD
Maraviroc—Dizziness—Zoledronate—osteoporosis	0.000187	0.000446	CcSEcCtD
Maraviroc—Pain—Estradiol—osteoporosis	0.000187	0.000444	CcSEcCtD
Maraviroc—Constipation—Estradiol—osteoporosis	0.000187	0.000444	CcSEcCtD
Maraviroc—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000187	0.000444	CcSEcCtD
Maraviroc—CCR5—Disease—IRS1—osteoporosis	0.000185	0.00254	CbGpPWpGaD
Maraviroc—Nausea—Pamidronate—osteoporosis	0.000184	0.000438	CcSEcCtD
Maraviroc—Dizziness—Conjugated Estrogens—osteoporosis	0.00018	0.000429	CcSEcCtD
Maraviroc—Vomiting—Zoledronate—osteoporosis	0.00018	0.000428	CcSEcCtD
Maraviroc—Rash—Zoledronate—osteoporosis	0.000179	0.000425	CcSEcCtD
Maraviroc—Gastrointestinal pain—Estradiol—osteoporosis	0.000178	0.000425	CcSEcCtD
Maraviroc—Dermatitis—Zoledronate—osteoporosis	0.000178	0.000424	CcSEcCtD
Maraviroc—Headache—Zoledronate—osteoporosis	0.000177	0.000422	CcSEcCtD
Maraviroc—CCR5—Disease—IL6R—osteoporosis	0.000174	0.00239	CbGpPWpGaD
Maraviroc—Vomiting—Conjugated Estrogens—osteoporosis	0.000173	0.000412	CcSEcCtD
Maraviroc—Abdominal pain—Estradiol—osteoporosis	0.000173	0.00041	CcSEcCtD
Maraviroc—Body temperature increased—Estradiol—osteoporosis	0.000173	0.00041	CcSEcCtD
Maraviroc—Rash—Conjugated Estrogens—osteoporosis	0.000172	0.000409	CcSEcCtD
Maraviroc—Dermatitis—Conjugated Estrogens—osteoporosis	0.000172	0.000409	CcSEcCtD
Maraviroc—Headache—Conjugated Estrogens—osteoporosis	0.000171	0.000406	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADCY5—osteoporosis	0.00017	0.00233	CbGpPWpGaD
Maraviroc—Nausea—Zoledronate—osteoporosis	0.000168	0.0004	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SPP1—osteoporosis	0.000165	0.00226	CbGpPWpGaD
Maraviroc—Nausea—Conjugated Estrogens—osteoporosis	0.000162	0.000385	CcSEcCtD
Maraviroc—Hypersensitivity—Estradiol—osteoporosis	0.000161	0.000383	CcSEcCtD
Maraviroc—Asthenia—Estradiol—osteoporosis	0.000157	0.000373	CcSEcCtD
Maraviroc—Pruritus—Estradiol—osteoporosis	0.000154	0.000367	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000151	0.00208	CbGpPWpGaD
Maraviroc—Diarrhoea—Estradiol—osteoporosis	0.000149	0.000355	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IRS2—osteoporosis	0.000149	0.00204	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—osteoporosis	0.000146	0.002	CbGpPWpGaD
Maraviroc—Dizziness—Estradiol—osteoporosis	0.000144	0.000343	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ESR1—osteoporosis	0.000139	0.00191	CbGpPWpGaD
Maraviroc—Vomiting—Estradiol—osteoporosis	0.000139	0.00033	CcSEcCtD
Maraviroc—Rash—Estradiol—osteoporosis	0.000138	0.000327	CcSEcCtD
Maraviroc—Dermatitis—Estradiol—osteoporosis	0.000137	0.000327	CcSEcCtD
Maraviroc—Headache—Estradiol—osteoporosis	0.000137	0.000325	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—IRS1—osteoporosis	0.00013	0.00178	CbGpPWpGaD
Maraviroc—Nausea—Estradiol—osteoporosis	0.00013	0.000308	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—POMC—osteoporosis	0.000125	0.00171	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000123	0.00168	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6R—osteoporosis	0.000122	0.00167	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1—osteoporosis	0.00012	0.00165	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	0.000108	0.00149	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	0.000107	0.00147	CbGpPWpGaD
Maraviroc—CCR5—Disease—MYC—osteoporosis	0.000103	0.00142	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—osteoporosis	0.000103	0.00141	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—osteoporosis	9.2e-05	0.00126	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—osteoporosis	7.76e-05	0.00106	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MYC—osteoporosis	7.23e-05	0.000991	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—osteoporosis	7.21e-05	0.000989	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—osteoporosis	6.52e-05	0.000894	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PKM—osteoporosis	6.15e-05	0.000843	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FDPS—osteoporosis	6.15e-05	0.000843	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PGLS—osteoporosis	5.83e-05	0.000799	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPD2—osteoporosis	5.83e-05	0.000799	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—osteoporosis	5.43e-05	0.000745	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ATIC—osteoporosis	5.33e-05	0.000731	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNP—osteoporosis	5.33e-05	0.000731	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—OXCT1—osteoporosis	4.53e-05	0.000621	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA2—osteoporosis	4.53e-05	0.000621	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MGLL—osteoporosis	4.42e-05	0.000606	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—IDH2—osteoporosis	3.76e-05	0.000515	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.53e-05	0.000484	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ACP5—osteoporosis	3.44e-05	0.000471	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TPI1—osteoporosis	3.19e-05	0.000438	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—P4HB—osteoporosis	3e-05	0.000412	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GAPDH—osteoporosis	2.95e-05	0.000404	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—RAP1A—osteoporosis	2.87e-05	0.000393	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ENO1—osteoporosis	2.32e-05	0.000318	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PSMA2—osteoporosis	2.29e-05	0.000313	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PSMA5—osteoporosis	2.29e-05	0.000313	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.86e-05	0.000254	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADCY5—osteoporosis	1.52e-05	0.000208	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—osteoporosis	1.51e-05	0.000207	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—osteoporosis	1.39e-05	0.000191	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—osteoporosis	1.11e-05	0.000153	CbGpPWpGaD
